Lateral neck lymph nodes are a significant consideration in the surgical management of patients with DTC. When current guidelines formulated by the ATA and by other international medical societies are followed, initial evaluation of the DTC patient with ultrasound (or other modalities when indicated) will help to identify lateral neck lymph nodes of concern. These findings should be addressed using fine-needle aspiration biopsy. A comprehensive neck dissection of at least nodal levels IIa, III, IV, and Vb should be performed when indicated to optimize disease control.

Renal cell carcinoma is the most common primary tumor of the kidney, with more than 30,000 new cases diagnosed in the United States each year. With the widespread use of cross-sectional imaging, many tumors are detected incidentally. Single- and multidetector computed tomography (CT) have helped refine the diagnostic work-up of renal masses by allowing image acquisition in various phases of renal enhancement after intravenous administration of a single bolus of contrast material. The scanning protocol should include unenhanced CT followed by imaging during the corticomedullary and nephrographic phases of enhancement. The nephrographic phase is the most sensitive for tumoral detection, while the corticomedullary phase is essential for imaging the renal veins for possible tumoral extension and the parenchymal organs for potential metastases. Knowledge of the tumoral stage at the time of diagnosis is essential for prognosis and surgical planning. The accuracy of CT for staging has been reported to reach 91%, with most staging errors related to the diagnosis of perinephric extension of tumor. Three-dimensional CT provides the urologist with an interactive road map of the relationships among the tumor, the major vessels, and the collecting system. This information is particularly critical if the tumor extends into the inferior vena cava and if nephron-sparing surgery is being planned.

Extranodal spread of lymphoma often affects the genitourinary system, with the kidneys being the most commonly involved organs. Contrast material-enhanced computed tomography (CT) remains the modality of choice for the detection, diagnosis, staging, and monitoring of renal lymphoma. Magnetic resonance (MR) imaging is particularly useful in patients in whom intravenous administration of iodinated contrast material is contraindicated. Ultrasonography (US), although very valuable for diagnosing lymphoma in the testis or epididymis, is less sensitive than CT and MR imaging for detecting renal lymphoma. Typical imaging findings of renal lymphoma include multiple poorly enhancing or hypoechoic masses, retroperitoneal tumors directly invading the kidneys, bilateral renal enlargement, and perirenal soft-tissue masses. Cystic lesions and tumors predominantly affecting the renal sinus and collecting system are uncommon. Unless the renal lesions manifest in the setting of widespread lymphoma, percutaneous biopsy is indicated to differentiate lymphoma from metastases, hypovascular renal cell carcinoma, uroepithelial carcinoma, or atypical infection, with US routinely being used to guide the procedure. Current immunohistochemical techniques allow accurate diagnosis and characterization of renal lymphoma. Radiologists should be familiar with both typical and atypical manifestations of renal lymphoma and should recommend imaging-guided percutaneous biopsy for diagnostic confirmation to avoid unnecessary nephrectomy.

MR imaging is superior to Doppler US and CT in diagnosis of malignant ovarian masses. There is little variation among conventional US, CT, and MR imaging as regards staging.